Pharma Summit on April 24-26, 2023 in Frankfurt am Main, Germany

We are organizing a three-day-long summit on the Global Pharma and Drug Delivery Summit, which will be held on the 24th-26th of April 2023. This scientific meeting offers a great opportunity to share expertise speaking the current advancements involved in the Pharmaceutical Industry and Academia. The knowledgeable intriguing sessions will create a superlative platform to get acquainted with the latest trends, advancements, and future of the pharmaceutical sciences. It is a wonderful moment for all the participants as it provides a networking opportunity to collaborate with the world-class Pharmaceutical and healthcare industry.

This Global Conference on Pharma Summit will focus on a variety of advanced research topics including Formulation Technologies, Pharmacology & Toxicology, Drug Discovery & Development Biodrugs, Biomolecules & Therapeutics, Drug Delivery, Regulatory Affairs and Intellectual Property Rights, Pharmacogenomics, Pharmacovigilance and Drug Safety, GMP & GDP, Nanomedicine, Translational Medicine, Pharma Economics.

Join us for three intensive and interesting days of discussing contemporary challenges and new advancements in pharmaceutical Science and Drug delivery. We invite you to contribute and help to shape the event through submissions of your research abstracts and e-posters. Also, high-quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Pharmaceutics and Drug delivery at this Conference.

Pharma Summit 2023 warmly welcomes all eminent delegates to participate in the upcoming three-day conference, highlighting the theme “Together with Pharma Masterminds: Opportunities, Technology, and Challenges”. The Pharma Forum is the event for anyone involved in the pharma, biotech, and healthcare industry-from the educational sessions, to the networking to the appointments, share ideas and collaborate with peers and external stakeholders.